From: A new validated stability-indicating RP-HPLC method for simultaneous quantification of dolutegravir and lamivudine in bulk and pharmaceutical dosage form
% of target concentration
Lamivudine (% recovery)
Dolutegravir (% recovery)
50
100.16
101.48
100
99.03
99.21
150
100.21
100.48
Mean % recovery (n = 3)
99.8
100.4
%RSD
0.67
1.13